Westin U, Fryksmark U, Polling A, Ohlsson K
Department of Otolaryngology and Head and Neck Surgery, Malmö General Hospital, University of Lund, Sweden.
Acta Otolaryngol. 1994 Mar;114(2):199-202. doi: 10.3109/00016489409126042.
Human secretory leucocyte proteinase inhibitor (SLPI) is a low-molecular weight, acid-stable inhibitor of polymorph-nuclear granulocyte elastase and cathepsin G. Previous reports have demonstrated the existence of SLPI in the respiratory tract, salivary glands and cervical mucosa. Positive staining for SLPI using immunohistochemical techniques has been reported in serous glands in nasal mucosa. We now confirm this observation and show, using in situ hybridization, that the pattern of expression of mRNA corresponds to the distribution of the encoded protein, SLPI. This, together with the high concentration of SLPI in nasal secretions, confirms the hypothesis of a local production of SLPI in the mucous membranes.
人分泌型白细胞蛋白酶抑制剂(SLPI)是一种低分子量、酸稳定的多形核粒细胞弹性蛋白酶和组织蛋白酶G抑制剂。先前的报道已证实在呼吸道、唾液腺和宫颈黏膜中存在SLPI。据报道,使用免疫组化技术对鼻黏膜浆液性腺中的SLPI进行染色呈阳性。我们现在证实了这一观察结果,并通过原位杂交表明,mRNA的表达模式与编码蛋白SLPI的分布相对应。这一点,再加上鼻分泌物中高浓度的SLPI,证实了黏膜中SLPI局部产生的假说。